Very Long-chain Acyl-coa Dehydrogenase Deficiency

• CLINICAL_TRIALS trial_result · 2024-01-30
  Clinical Trial Update: Fatty Acid Oxidation Defects and Insulin Sensitivity [NA]

  Clinical trial update reporting completed study on fatty acid oxidation defects and insulin sensitivity with posted results.

• CLINICAL_TRIALS trial_result · 2021-12-08
  Clinical Trial Update: Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies [Phase 2]

  A Phase 2 extension study update for subjects previously enrolled in triheptanoin studies in long-chain fatty acid oxidation disorders, with…

• CLINICAL_TRIALS trial_result · 2021-02-11
  Clinical Trial Update: A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) [Phase 2]

  Phase 2 clinical trial evaluating UX007 (triheptanoin) in participants with long-chain fatty acid oxidation disorders (LC-FAOD) has complete…

• CLINICAL_TRIALS trial_result · 2020-04-21
  Clinical Trial Update: High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders [Phase 1, Phase 2]

  Clinical trial update on a high protein diet in patients with long-chain fatty acid oxidation disorders, including VLCAD deficiency and trif…

• CLINICAL_TRIALS trial_result · 2017-03-23
  Clinical Trial Update: Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder [Phase 2]

  Phase 2 clinical trial update on triheptanoin for long-chain fatty acid oxidation disorders with results posted in 2017.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-05-30
  Clinical Trial Update: Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects [Phase 2]

  Phase 2 trial evaluating bezafibrate’s effect on muscle metabolism in patients with fatty acid oxidation defects; the study status is comple…